0001493152-24-005509.txt : 20240313 0001493152-24-005509.hdr.sgml : 20240313 20240208184207 ACCESSION NUMBER: 0001493152-24-005509 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240208 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENELUX Corp CENTRAL INDEX KEY: 0001231457 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 2625 TOWNSGATE ROAD, SUITE 230 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91361 BUSINESS PHONE: 805-267-9889 MAIL ADDRESS: STREET 1: 2625 TOWNSGATE ROAD, SUITE 230 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91361 FORMER COMPANY: FORMER CONFORMED NAME: GENELUX CORP DATE OF NAME CHANGE: 20030508 CORRESP 1 filename1.htm

Genelux Corporation

2625 Townsgate Road, Suite 230

Westlake Village, California 91361

(805) 267-9889

February 8, 2024

Via Edgar

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn: Lauren Hamill

Re:	Genelux Corporation
	Registration Statement on Form S-3
	File No. 333-276847

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective at 4:00 p.m. Eastern Time on February 13, 2024, or as soon thereafter as is practicable.

Once the above-referenced Registration Statement has been declared effective, please orally confirm that event with Jason Kent of Cooley LLP, counsel to the registrant, at (212) 479-6044.

GENELUX CORPORATION

By:	/s/ Thomas Zindrick, J.D.
	Thomas Zindrick, J.D.
	President and Chief Executive Officer